<DOC>
	<DOCNO>NCT01765452</DOCNO>
	<brief_summary>The Aim study prove non-inferiority Closone Combination treatment Plavix Astrix .</brief_summary>
	<brief_title>Phase IV Study Compare Efficacy Safety Plavix 75mg With Astrix 100mg Closone</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Subjects stable condition PostPercutaneous Coronary Artery Intervention three month 20~86 year old Willing adhere protocol requirement sign inform consent form Subject undergo fail DrugStent Implantation Subjects take anticoagulant , antithrombotic regularlly ( â‰¥ 2weeks month ) study , plan continuous treatment study ( Except Aspirin alone combination Aspirin Clopidogrel ) Subjects history substance alchol abuse Subjects history hypersensitivity Clopidogrel , Aspirin NSAIDS Subjects Aspirin NSAIDsinduced Asthma history Subjects Severe hepatopathy ( AST ALT &gt; 5 time upper limit normal ) Subjects Severe nephropathy ( Cr &gt; 3 time upper limit normal ) Subjects hemorrhage like gastric ulcer , intracranial hemorrhage etc . Subjects high risk hemorrhage like blood coagulation disorder , uncontrolled severe hypertension , active bleeding , history severe bleed subject pregnant , breastfeed Subjects use medically acceptable birth control Subjects unsuitable take Investigational product due medical/mental condition Subjects inherently Galactose malobsorption , Lactase deficiency GlucoseGalactose malobsorption</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>